CCRC - Certified Clinical Research Coordinator Study and Site Management Questions and Answers — Questions and Answers
Question 1: A Clinical Research Coordinator (CRC) at a busy site discovers that a blood sample required for a key secondary endpoint, scheduled for the Week 4 visit, was missed for a participant who has already left the clinic. The protocol's visit window for this draw has now passed. How should the CRC best manage and document this situation?
- Ask the participant to return immediately, even though it is outside the protocol-defined window, to ensure the data is collected.
- Ignore the missed sample since it is for a secondary, not primary, endpoint.
- Wait until the next scheduled visit to draw the sample and label it as the Week 4 sample to complete the case report form.
- Document the event as a protocol deviation and report it to the investigator and, if required, the sponsor/CRO. (Correct answer)
Correct answer: Document the event as a protocol deviation and report it to the investigator and, if required, the sponsor/CRO.
According to Good Clinical Practice (GCP), any departure from the protocol-approved procedures constitutes a protocol deviation. It must be documented accurately and reported to ensure data integrity and participant safety are not compromised. Attempting to collect the sample outside the window or mislabeling a future sample would be falsification of data. Ignoring the issue, even for a secondary endpoint, is inappropriate and compromises the quality of the study data.
Question 2: Which of the following is the most appropriate and GCP-compliant method for a Principal Investigator (PI) to document the assignment of study-related tasks to qualified site staff?
- A verbal agreement made with each staff member during a team meeting.
- An email from the PI to the sponsor listing the names of the research team members.
- A signed and dated Delegation of Authority (DoA) Log specifying tasks, start/end dates, and staff qualifications. (Correct answer)
- A single note-to-file written by the CRC after the study has been completed, summarizing who did what.
Correct answer: A signed and dated Delegation of Authority (DoA) Log specifying tasks, start/end dates, and staff qualifications.
The Delegation of Authority (DoA) Log is the standard, essential document used to formally record which study-specific duties have been assigned by the PI to specific, qualified individuals on the team. This log provides a contemporaneous record that is crucial for regulatory compliance and is often reviewed during monitoring visits and audits. Verbal agreements, informal emails, or retrospective notes are not sufficient to meet GCP standards for documenting delegation.
Question 3: During a site close-out visit, the Clinical Research Coordinator (CRC) and the monitor are reconciling the investigational product (IP) accountability records. What is the primary purpose of this reconciliation?
- To determine the final payment owed to the site for dispensing the IP.
- To ensure all IP units were correctly dispensed, returned to the sponsor, or appropriately destroyed, accounting for every unit received. (Correct answer)
- To identify which participants were most compliant with the treatment regimen for the final study report.
- To finalize the recruitment statistics for the study based on the number of participants who received IP.
Correct answer: To ensure all IP units were correctly dispensed, returned to the sponsor, or appropriately destroyed, accounting for every unit received.
IP accountability is a critical GCP requirement to ensure the product was used only as specified in the protocol and to prevent diversion. The reconciliation process at the close-out visit provides a final accounting of every IP unit received at the site, confirming it was either dispensed to a participant, returned to the sponsor, or destroyed according to procedure. While dispensing data may inform other analyses, the primary purpose of this specific activity is regulatory compliance and product control.
Question 4: A new investigational product (IP) shipment is scheduled to arrive. The protocol specifies the IP must be stored between 2-8°C. The CRC notes that the temperature monitoring device for the site's drug storage refrigerator has not been calibrated in over a year. What is the most critical immediate action for the CRC?
- Notify the sponsor/CRO and arrange for an immediate calibration of the device before accepting the IP shipment. (Correct answer)
- Relocate the new IP shipment to a standard breakroom refrigerator temporarily.
- Accept the shipment and begin recording the temperatures manually every hour with a standard thermometer.
- Proceed with dispensing IP to participants as scheduled from existing stock.
Correct answer: Notify the sponsor/CRO and arrange for an immediate calibration of the device before accepting the IP shipment.
Maintaining the integrity of the investigational product is paramount for patient safety and data validity. GCP guidelines require that storage conditions are acceptable and equipment is properly maintained. An uncalibrated temperature monitoring device means there is no reliable record of the storage temperature. The CRC must ensure equipment is calibrated *before* using it to store the new IP shipment and should communicate this issue to the sponsor immediately.
Question 5: Which of the following documents is essential to have completed, signed, and filed in the site's regulatory binder BEFORE a clinical trial can be initiated at the site?
- The final, signed clinical study report.
- A log of all participants who have successfully completed the study.
- A record of all Serious Adverse Event reports submitted to the sponsor.
- A signed and dated FDA Form 1572. (Correct answer)
Correct answer: A signed and dated FDA Form 1572.
The FDA Form 1572, or Statement of Investigator, is a legally binding agreement between the investigator and the FDA. By signing it, the investigator commits to conducting the study in accordance with federal regulations. This form, along with IRB approval and the protocol signature page, is a foundational document that must be in place before any study activities, including participant recruitment, can begin.
Question 6: To ensure an efficient interim monitoring visit where the primary purpose is source data verification (SDV), which of the following is the most important preparatory task for the CRC?
- Schedule all upcoming participant visits for the day the Clinical Research Associate (CRA) is on-site.
- Wait for the CRA to arrive to ask what data needs to be entered into the electronic data capture (EDC) system.
- Ensure all source documents are complete, organized, and readily accessible for the subjects being monitored. (Correct answer)
- Prepare a detailed summary of recruitment and retention challenges for the sponsor.
Correct answer: Ensure all source documents are complete, organized, and readily accessible for the subjects being monitored.
The core function of Source Data Verification (SDV) is the comparison of data entered into the EDC system against the original source documents to ensure accuracy and completeness. The most crucial step for the CRC to facilitate this process is to have all necessary source documents—such as medical records, lab reports, and participant diaries—organized and available for the monitor's review. This preparation is key to a productive and efficient monitoring visit.
CCRC - Certified Clinical Research Coordinator Study and Site Management Questions and Answers
A Clinical Research Coordinator (CRC) at a busy site discovers that a blood sample required for a key secondary endpoint, scheduled for the Week 4 visit, was missed for a participant who has already left the clinic.
The protocol's visit window for this draw has now passed.
How should the CRC best manage and document this situation?